- All sections
- A - Human necessities
- A61P - Specific therapeutic activity of chemical compounds or medicinal preparations
- A61P 31/16 - Antivirals for RNA viruses for influenza or rhinoviruses
Patent holdings for IPC class A61P 31/16
Total number of patents in this class: 3053
10-year publication summary
|
101
|
97
|
86
|
139
|
226
|
233
|
367
|
379
|
308
|
88
|
| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 |
Principal owners for this class
| Owner |
All patents
|
This class
|
|---|---|---|
| Shionogi & Co., Ltd. | 914 |
43 |
| Novartis AG | 11238 |
26 |
| Medicago Inc. | 203 |
24 |
| F. Hoffmann-La Roche AG | 7958 |
21 |
| Janssen Vaccines & Prevention B.V. | 337 |
20 |
| Regeneron Pharmaceuticals, Inc. | 3650 |
20 |
| Sunshine Lake Pharma Co., Ltd. | 542 |
20 |
| Academia Sinica | 888 |
19 |
| University of Rochester | 1243 |
19 |
| Glaxosmithkline Biologicals S.A. | 1701 |
17 |
| Cocrystal Pharma, Inc. | 43 |
17 |
| Emory University | 1498 |
17 |
| Humabs Biomed SA | 115 |
17 |
| Intervet Inc. | 848 |
17 |
| Intervet International B.V. | 1235 |
17 |
| MedImmune, LLC | 467 |
17 |
| The Regents of the University of California | 18943 |
14 |
| Icahn School of Medicine at Mount Sinai | 859 |
14 |
| VIR Biotechnology, Inc. | 114 |
14 |
| Modernatx, Inc. | 1181 |
13 |
| Other owners | 2667 |